MODEL FOR END STAGE LIVER DISEASE SCORE INCREASED

This adverse event was reported 39 times

These drugs are most commonly taken by patients reporting MODEL FOR END STAGE LIVER DISEASE SCORE INCREASED:

# Drug Count
0 URSODIOL 8
1 URSOSIOL 8
2 ERGOCALCIFEROL 7
3 LACTULOSE 7
4 FUROSEMIDE 6
5 RIFAXIMIN 6
6 SPIRONOLACTONE 6
7 ACETYLCYSTEINE 5
8 OMEPRAZOLE 5
9 OMEPRAZOLE MAGNESIUM 5
See all common drugs associated with MODEL FOR END STAGE LIVER DISEASE SCORE INCREASED

MODEL FOR END STAGE LIVER DISEASE SCORE INCREASED is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ODEVIXIBAT 1 0.0025
1 ULIPRISTAL ACETATE 1 0.0020
2 ZINC SULFATE INJECTION, 2 0.0007
3 ZINC SULFATE INJECTION 2 0.0007
4 ACETYLCYSTEINE 5 0.0005
5 CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE 1 0.0005
6 URSOSIOL 8 0.0004
7 URSODIOL 8 0.0004
8 CEVIMELINE HYDROCHLORIDE 1 0.0004
9 RIFAXIMIN 6 0.0003
See all drugs enriched for association with MODEL FOR END STAGE LIVER DISEASE SCORE INCREASED

MODEL FOR END STAGE LIVER DISEASE SCORE INCREASED is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Ileal Bile Acid Transporter Inhibitor [EPC] 1 0.0022
1 Bile Acid [EPC] 8 0.0003
2 Rifamycin Antibacterial [EPC] 9 0.0002
3 Bile Acid Sequestrant [EPC] 2 0.0002
4 Vitamin K [EPC] 1 0.0001
5 Antidote [EPC] 7 0.0001
6 Stimulant Laxative [EPC] 1 0.0001
7 Ester Local Anesthetic [EPC] 3 0.0001
8 Aluminum Complex [EPC] 1 0.0000
9 Antimycobacterial [EPC] 1 0.0000
See all drug classes enriched for association with MODEL FOR END STAGE LIVER DISEASE SCORE INCREASED